Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MyPal

Financiado

Cerrado

MyPal Fostering Palliative Care of Adults and Children with Cancer through Adva...

MyPal Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems MyPal aims to foster early palliative care for cancer patients by leveraging patient reported outcome (PRO) systems through their adaptation to the personal needs of the cancer patient and his/her caregiver(s). Through this interv... ver más

31/12/2022

CENTRE FOR RESEARC...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAP... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 18 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-12-31

SC1-BHC-23-2018: Novel patient-centred approaches fo...

I+D

Cerrada hace 6 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

18 Participantes

CENTRE FOR RESEARCH AND TECH...

556.94K€ | Lider

COMPANIA VALENCIANA DE ALUMI...

1.79M€ | Participante

EUROPEAN ASSOCIATION FOR PAL...

96.25K€ | Participante

GENERAL HOSPITAL OF THESSALO...

N.D. | Participante

Proyectos interesantes

SISAQOL-IMI

Medical Technol...

Data Science

6M€ Cerrado

ONCORELIEF

Medical Technol...

Data Science

5M€ Cerrado

e-QuoL

Medical Technol...

Health Informat...

7M€ Cerrado

MyPath

Medical Technol...

Data Science

5M€ Cerrado

PRISMA

Medical Technol...

Data Science

2M€ Cerrado

4D PICTURE

Medical Technol...

Data Science

9M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 49 meses Fecha Inicio: 2018-11-21
Fecha Fin: 2022-12-31

Líder del proyecto

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAP... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto MyPal aims to foster early palliative care for cancer patients by leveraging patient reported outcome (PRO) systems through their adaptation to the personal needs of the cancer patient and his/her caregiver(s). Through this intervention, MyPal aspires to empower cancer patients (and their family members) in capturing more accurately their conditions, communicate them with a seamless and effective way to their healthcare providers and, ultimately, foster the time for action through the rapid identification of important deviations in the patient’s state and QoL. Providing this information in a timely and comprehensive manner throughout the disease course will reinforce the potential for applying a patient-centred and integrated palliative care approach for cancer with the participation of all relevant healthcare providers (i.e. oncologists, specialized physicians, psychologists, nurses), which is necessary to cope with the specific disease. In order to accomplish its mission, MyPal will exploit technological advances on digital health to support patients, family members and healthcare providers in gaining value through this systematic and comprehensive PRO-based intervention. Overall, the foreseen advancement through MyPal reflects a paradigm shift from passive patient reporting based on conventional PRO approaches to active patient engagement and a closed-loop approach (bridging the gap between patient reporting and effective actions by healthcare providers to meet the varying patient needs) for coping with palliative care challenges in cancer. MyPal will demonstrate and validate the proposed intervention in two clinical studies, an RCT for adults with hematologic cancers and an observational study for children suffering from solid tumors and hematologic malignancies, hence targeting different age groups and cancer types. The clinical studies will be conducted in diverse healthcare settings in 6 clinical sites from 5 European countries.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores